Euglena Co., Ltd. (2931.T)
JPY 399.0
(0.76%)
JPY 399.0
(0.76%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 37.92 Billion JPY | -9.45% |
| 2021 | 41.87 Billion JPY | 602.15% |
| 2020 | 5.96 Billion JPY | -6.3% |
| 2019 | 6.36 Billion JPY | 7.29% |
| 2018 | 5.93 Billion JPY | 85.24% |
| 2017 | 3.2 Billion JPY | 52.28% |
| 2016 | 2.1 Billion JPY | 15.44% |
| 2015 | 1.82 Billion JPY | 118.21% |
| 2014 | 834.98 Million JPY | 16.44% |
| 2013 | 717.08 Million JPY | 250.93% |
| 2012 | 204.33 Million JPY | -22.71% |
| 2011 | 264.39 Million JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 39.08 Billion JPY | -4.23% |
| 2023 Q3 | 39.01 Billion JPY | -0.18% |
| 2023 Q1 | 40.8 Billion JPY | 7.61% |
| 2022 FY | 37.92 Billion JPY | -9.45% |
| 2022 Q3 | 39 Billion JPY | 0.55% |
| 2022 Q2 | 38.78 Billion JPY | -2.48% |
| 2022 Q1 | 39.77 Billion JPY | 0.0% |
| 2022 Q4 | 37.92 Billion JPY | -2.77% |
| 2021 Q1 | 10.28 Billion JPY | 14.8% |
| 2021 FY | 41.87 Billion JPY | 602.15% |
| 2021 Q3 | 41.87 Billion JPY | 20.42% |
| 2021 Q2 | 34.77 Billion JPY | 238.03% |
| 2020 Q3 | 5.96 Billion JPY | 2.82% |
| 2020 Q1 | 5.39 Billion JPY | -4.02% |
| 2020 Q4 | 8.96 Billion JPY | 50.26% |
| 2020 FY | 5.96 Billion JPY | -6.3% |
| 2020 Q2 | 5.8 Billion JPY | 7.43% |
| 2019 Q3 | 6.36 Billion JPY | -1.16% |
| 2019 Q4 | 5.62 Billion JPY | -11.62% |
| 2019 FY | 6.36 Billion JPY | 7.29% |
| 2019 Q1 | 6.13 Billion JPY | -8.51% |
| 2019 Q2 | 6.43 Billion JPY | 5.01% |
| 2018 Q1 | 5.92 Billion JPY | 35.57% |
| 2018 Q4 | 6.7 Billion JPY | 12.98% |
| 2018 Q3 | 5.93 Billion JPY | 13.16% |
| 2018 FY | 5.93 Billion JPY | 85.24% |
| 2018 Q2 | 5.24 Billion JPY | -11.52% |
| 2017 Q3 | 3.2 Billion JPY | 1.58% |
| 2017 Q1 | 3.31 Billion JPY | -6.1% |
| 2017 FY | 3.2 Billion JPY | 52.28% |
| 2017 Q4 | 4.37 Billion JPY | 36.47% |
| 2017 Q2 | 3.15 Billion JPY | -4.78% |
| 2016 Q4 | 3.52 Billion JPY | 67.65% |
| 2016 FY | 2.1 Billion JPY | 15.44% |
| 2016 Q3 | 2.1 Billion JPY | 1.68% |
| 2016 Q2 | 2.06 Billion JPY | 4.72% |
| 2016 Q1 | 1.97 Billion JPY | -6.9% |
| 2015 Q2 | 1.48 Billion JPY | 50.26% |
| 2015 FY | 1.82 Billion JPY | 118.21% |
| 2015 Q4 | 2.12 Billion JPY | 16.45% |
| 2015 Q3 | 1.82 Billion JPY | 22.38% |
| 2015 Q1 | 990.83 Million JPY | -25.61% |
| 2014 Q3 | 834.98 Million JPY | 51.62% |
| 2014 Q2 | 550.69 Million JPY | -72.67% |
| 2014 Q1 | 2.01 Billion JPY | 161.07% |
| 2014 Q4 | 1.33 Billion JPY | 59.51% |
| 2014 FY | 834.98 Million JPY | 16.44% |
| 2013 Q2 | 645.45 Million JPY | -8.42% |
| 2013 Q3 | 717.08 Million JPY | 11.1% |
| 2013 FY | 717.08 Million JPY | 250.93% |
| 2013 Q4 | 771.89 Million JPY | 7.64% |
| 2013 Q1 | 704.78 Million JPY | 360.97% |
| 2012 FY | 204.33 Million JPY | -22.71% |
| 2012 Q4 | 152.89 Million JPY | 0.0% |
| 2011 FY | 264.39 Million JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.65 Billion JPY | -2194.534% |
| BEAUTY GARAGE Inc. | 6.49 Billion JPY | -484.09% |
| Axas Holdings Co.,Ltd. | 14.58 Billion JPY | -160.085% |
| C.I. Medical Co.,Ltd. | 21.36 Billion JPY | -77.479% |
| Kao Corporation | 757.7 Billion JPY | 94.995% |
| Niitaka Co., Ltd. | 9.35 Billion JPY | -305.305% |
| Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 61.747% |
| Shiseido Company, Limited | 615.1 Billion JPY | 93.835% |
| Lion Corporation | 188.22 Billion JPY | 79.853% |
| Mandom Corporation | 20.05 Billion JPY | -89.081% |
| Ivy Cosmetics Corporation | 1.32 Billion JPY | -2758.159% |
| Milbon Co., Ltd. | 7.45 Billion JPY | -408.367% |
| Nippon Shikizai, Inc. | 13.56 Billion JPY | -179.658% |
| Fancl Corporation | 30.56 Billion JPY | -24.058% |
| KOSÉ Corporation | 88.61 Billion JPY | 57.207% |
| Cota Co., Ltd. | 3.85 Billion JPY | -884.313% |
| HABA Laboratories,Inc. | 3.92 Billion JPY | -866.388% |
| C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -1104.314% |
| Pola Orbis Holdings Inc. | 33.26 Billion JPY | -14.013% |
| Noevir Holdings Co., Ltd. | 24.04 Billion JPY | -57.739% |
| Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -3463.796% |
| Almado, Inc. | 1.94 Billion JPY | -1848.338% |
| I-ne CO., LTD. | 8.57 Billion JPY | -342.084% |
| Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -677.09% |
| Liberta Co.,Ltd. | 3.88 Billion JPY | -876.472% |
| AXXZIA Inc. | 2 Billion JPY | -1790.002% |
| S.T. Corporation | 12.01 Billion JPY | -215.727% |
| Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 39.475% |
| Earth Corporation | 60.4 Billion JPY | 37.22% |
| Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | -386.291% |
| Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -2250.956% |
| Ya-Man Ltd. | 3.97 Billion JPY | -853.672% |
| MTG Co., Ltd. | 11.73 Billion JPY | -223.043% |
| TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -808.948% |
| SHOBIDO Corporation | 8.89 Billion JPY | -326.221% |
| Artnature Inc. | 23.42 Billion JPY | -61.873% |
| Pigeon Corporation | 19.34 Billion JPY | -95.989% |
| Unicharm Corporation | 345.37 Billion JPY | 89.02% |
| Paltac Corporation | 222.34 Billion JPY | 82.944% |
| CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | -32.994% |